Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC

BSE2820.8550.55 (+1.82 %)

PREV CLOSE ( ) 2770.30

OPEN PRICE ( ) 2804.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 5148

TODAY'S LOW / HIGH ( )2759.00 2834.15

52 WK LOW / HIGH ( )1924.3 3515.95

NSE2819.1048.8 (+1.76 %)

PREV CLOSE( ) 2770.30

OPEN PRICE ( ) 2821.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 2819.10 (419)

VOLUME 69313

TODAY'S LOW / HIGH( ) 2758.10 2835.00

52 WK LOW / HIGH ( )1921 3515.7

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-11 1924

Management Info

Renu Sud Karnad - Chairman Bhushan Akshikar - Managing Director

Registered Office

Address Gsk House, Dr. Annie Besant Road,Worli,,
Mumbai,
Maharashtra-400030

Phone 022-24959595

Email askus@gsk.com / in.investorquery@gsk.com

Website www.gsk-india.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

26Aug Glaxosmithkline Pharmaceuticals trades
Glaxosmithkline Pharmaceuticals is currently trading at Rs. 2807.00, up..

25Aug Glaxosmithkline Pharmaceuticals forays
Glaxosmithkline Pharmaceuticals has forayed into Indian Oncology market..

25Aug GlaxoSmithKline Pharmaceuticals infor
GlaxoSmithKline Pharmaceuticals has informed that it enclosed a press re..

25Aug Glaxosmithkline Pharmaceuticals moves
Glaxosmithkline Pharmaceuticals is currently trading at Rs. 2807.20, up..

04Aug GlaxoSmithKline Pharmaceuticals inform
GlaxoSmithKline Pharmaceuticals has informed that in reference to the co..

Financials

Rs. in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	2047	9190.6
Gross Profit	2785.7	12484.4
Operating Profit	2945.1	13118.5
Net Sales	8048.3	37234.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Cohance Lifesciences (BSE) 1011.20 (9.54%)	M.Cap ( in Cr)38685.19
Procter&Gamble Healt (BSE) 6525.95 (0.94%)	M.Cap ( in Cr)10832.67
Haleos Labs (BSE) 1165.65 (4.22%)	M.Cap ( in Cr)352.41
Caplin Point Lab (BSE) 2176.05 (1.86%)	M.Cap ( in Cr)16540.53
Jubilant Pharmova (BSE) 1105.90 (3.38%)	M.Cap ( in Cr)17614.90

Shareholding Pattern

	PROMOTERS	75%
	NON-INSTITUTION	12.41%
	MUTUAL FUNDS/UTI	5.17%
	FI/BANKS/INSURANCE	2.41%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Nippon India Pharma...	3.63
360 ONE Quant Fund-Reg(G)	3.13
Bajaj Finserv Healt...	2.59
Aditya Birla SL MNC...	2.48
Tata Nifty MidSmall...	2.37
Motilal Oswal Nifty...	2.36
ICICI Pru Quant Fund(G)	2.34

Risk Disclosures on Derivatives

Smart Quotes

GLAXOSMITHKLINE PHARMACEUTICALS LTD.